Cargando…

Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells

The aim of the present study was to investigate the activities of novel synthetic epidermal growth factor receptor (EGFR) inhibitors (ZINC05463076, ZINC2102846 and ZINC19901103) against prostate tumors, in vitro models and investigate the potential underlying mechanisms. A panel of prostate tumor ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhi, Yi, Wu, Xiaojun, Shen, Wenhao, Wang, Yongquan, Zhou, Xiaozhou, He, Peng, Pan, Jinhong, Chen, Zhiwen, Li, Weibing, Zhou, Zhansong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202546/ https://www.ncbi.nlm.nih.gov/pubmed/30405791 http://dx.doi.org/10.3892/ol.2018.9438

Ejemplares similares

Long-Term Evaluation of Patients Undergoing Genitoplasty due to Disorders of Sex Development: Results from a 14-Year Follow-Up
por: Zhang, Heng, et al.
Publicado: (2013)

Prostatic fluid exosome-mediated microRNA-155 promotes the pathogenesis of type IIIA chronic prostatitis
por: Zhao, Baixiong, et al.
Publicado: (2021)

Connexin 26 is Down-Regulated by KDM5B in the Progression of Bladder Cancer
por: Li, Xin, et al.
Publicado: (2013)

In vivo targeting capacities of different nanoparticles to prostate tissues based on a mouse model of chronic bacterial prostatitis
por: Hu, Ruimin, et al.
Publicado: (2022)

Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II/III interstitial cystitis/bladder pain syndrome
por: Jiang, Tao, et al.
Publicado: (2020)

Notch3 overexpression enhances progression and chemoresistance of urothelial carcinoma
por: Zhang, Heng, et al.
Publicado: (2017)

Photoselective sharp enucleation of the prostate with a front-firing 532-nm laser versus photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia: a randomised controlled trial with 1-year followup results
por: Liu, Zhengchao, et al.
Publicado: (2022)

Correction to: Photoselective sharp enucleation of the prostate with a front-firing 532-nm laser versus photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia: a randomised controlled trial with 1-year followup results
por: Liu, Zhengchao, et al.
Publicado: (2022)

Treatment and outcomes of urethral recurrence after orthotopic neobladder replacement in patients with bladder cancer — practice in a single centre
por: Zhou, Xiaozhou, et al.
Publicado: (2018)

Gene mutation profiling and clinical significances in patients with renal cell carcinoma
por: Wang, Yongquan, et al.
Publicado: (2023)

The Effect of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) on Semen Parameters in Human Males: A Systematic Review and Meta-Analysis
por: Fu, Weihua, et al.
Publicado: (2014)

Celastrol Suppresses Tumor Cell Growth through Targeting an AR-ERG-NF-κB Pathway in TMPRSS2/ERG Fusion Gene Expressing Prostate Cancer
por: Shao, Longjiang, et al.
Publicado: (2013)

Urethral orifice hyaluronic acid injections: a novel animal model of bladder outlet obstruction
por: Wang, Yongquan, et al.
Publicado: (2015)

Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma
por: Zhang, Dawei, et al.
Publicado: (2023)

Novel approaches against epidermal growth factor receptor tyrosine kinase inhibitor resistance
por: Heydt, Carina, et al.
Publicado: (2018)

Glucocorticoid nanoformulations relieve chronic pelvic pain syndrome and may alleviate depression in mice
por: Yang, Yang, et al.
Publicado: (2023)

Network Pharmacology Integrated Molecular Docking Revealed the Mechanism of Jianpi Yiqi Taohua Decoction Against Ulcerative Colitis
por: Jia, Lin, et al.
Publicado: (2022)

Pharmacological Interventions for Bacterial Prostatitis
por: Xiong, Situ, et al.
Publicado: (2020)

Development of epidermal growth factor receptor tyrosine kinase inhibitors against EGFR T790M. Mutation in non small-cell lung carcinoma
por: Wang, Yuli, et al.
Publicado: (2016)

Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes
por: Kharmate, Geetanjali, et al.
Publicado: (2016)

Toxic epidermal necrolysis induced by Lansoprazole: Pharmacologic considerations*
por: Gomes, Ciro Martins
Publicado: (2013)

Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer via Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
por: Wu, Yongrong, et al.
Publicado: (2022)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Targeting the Cardiotoxicity of Epidermal Growth Factor Receptor Inhibitors
por: Uprety, Dipesh, et al.
Publicado: (2020)

Effects and Potential Mechanism of Zhuyu Pill Against Atherosclerosis: Network Pharmacology and Experimental Validation
por: Pan, Yingying, et al.
Publicado: (2023)

Association Study of Polymorphisms of Epidermal Growth Factor and Epidermal Growth Factor Receptor With Benign Prostatic Hyperplasia in a Korean Population
por: Kim, Su Kang, et al.
Publicado: (2016)

Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer’s disease
por: Zhu, Jie, et al.
Publicado: (2018)

Correction: Epidermal Growth Factor Receptor in Prostate Cancer Derived Exosomes
por: Kharmate, Geetanjali, et al.
Publicado: (2016)

Dermatologic Toxicities in Epidermal Growth Factor Receptor and Multikinase Inhibitors
por: Eaby-Sandy, Beth, et al.
Publicado: (2012)

Epidermal growth factor receptor inhibitors related trichomegaly of Eyelashes
por: Maka, Vinayak V., et al.
Publicado: (2014)

Molecular Dynamics Analysis of Binding Sites of Epidermal Growth Factor Receptor Kinase Inhibitors
por: Li, Dong-Dong, et al.
Publicado: (2020)

Pharmacological activation of epidermal growth factor receptor signaling inhibits colitis-associated cancer in mice
por: Dubé, Philip E., et al.
Publicado: (2018)

The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011)

Epidermal Growth Factor-Containing Fibulin-Like Extracellular Matrix Protein 1 (EFEMP1) Acts as a Potential Diagnostic Biomarker for Prostate Cancer
por: Shen, Hao, et al.
Publicado: (2017)

Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin
por: Xue, Dong, et al.
Publicado: (2016)

Synthesis and multifaceted pharmacological activity of novel quinazoline NHE-1 inhibitors
por: Spasov, Alexander, et al.
Publicado: (2021)

Comparative study and discussion of diagenetic facies and conductivity characteristics based on experiments
por: Zhou, Xueqing, et al.
Publicado: (2022)

Sensitivities to various epidermal growth factor receptor‐tyrosine kinase inhibitors of uncommon epidermal growth factor receptor mutations L861Q and S768I: What is the optimal epidermal growth factor receptor‐tyrosine kinase inhibitor?
por: Banno, Eri, et al.
Publicado: (2016)

Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis
por: Howell, Mark C., et al.
Publicado: (2019)

Role of Delta/Notch-like epidermal growth factor-related receptor in gastric cancer patients and cells and its clinical significance
por: Tao, Hanchuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mf97ej2r1qj3cnj7d9fkfbjroq